Filter posts

Propel Small Business Innovation through Tax Reform

As CEO of an emerging clinical-stage biotech company, I lose over $10 million each year. …

How the Orphan Drug Tax Credit Leverages MDA’s Fight against Rare Genetic Diseases

In the early 1950s, a small group of concerned parents, people with muscular dystrophy and …

When is the Evidence “Enough” to Make a Health Care Decision?

At any given time, work is taking place in hundreds of laboratories throughout the country …

The Michael J. Fox Foundation Launches $10 Million Edmond J. Safra Core Programs

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has committed up to $10 million …

New BIO Survey on Effective FDA - Sponsor Communication During Drug Development

BIO is surveying members on their interactions with the FDA during the various stages of …

Unraveling the Mystery of Alzheimer’s Disease

Preeminent researchers from around the world gathered recently to tackle the science behind one of …

What’s Really Happening with the So-called ‘Blend Wall’? A Fuels America Briefing

The public dialog surrounding the Renewable Fuel Standard is robust- and filled with misinformation. On …

The Pivotal Role the Public Market Plays in Financing R&D

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle …

Untapped Potential in the Healthy Aging Marketplace

There are over 10,000 Baby Boomers entering Medicare every day and they have been instrumental …

President Obama Talks Climate Change: “We need to act”

On the steps of Georgetown University Tuesday, President Obama announced his multi-step plan to fight …